Clinical, metabolic and psychological outcomes and treatment costs of a prospective randomized trial based on different educational strategies to improve diabetes care (PRODIACOR)

Diabetic Medicine

Volumn 30, Issue 9, 2013, Pages 1102-1111

  Gagliardino, J J ^a   Lapertosa, S ^b   Pfirter, G ^a   Villagra, M ^b   Caporale, J E ^a   Gonzalez, C D ^c   Elgart, J ^a   Gonzalez L ^a   Cernadas, C ^c   Rucci, E ^a   Clark, C ^d  

^a University of La Plata CONICET   (Argentina)

^b Programa de Diabetes del Ministerio de Salud de la Provincia de Corrientes   (Argentina)

^c UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^d INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; TRIACYLGLYCEROL;

ADULT; AGED; ARGENTINA; ARTICLE; BODY MASS; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; DIABETES EDUCATION; DIABETIC PATIENT; DRUG USE; DYSLIPIDEMIA; FEMALE; GENERAL PRACTITIONER; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT CARE; PATIENT EDUCATION; PHYSICIAN; PRIMARY MEDICAL CARE; PRIVATE HEALTH INSURANCE; PROSPECTIVE STUDY; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SOCIAL SECURITY; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WELLBEING;

AGED; ARGENTINA; COSTS AND COST ANALYSIS; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; EDUCATION, MEDICAL, CONTINUING; FEMALE; FOLLOW-UP STUDIES; GENERAL PRACTITIONERS; HEALTH CARE COSTS; HEALTH PROMOTION; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; HYPERLIPIDEMIAS; HYPERTENSION; MALE; MIDDLE AGED; PATIENT DROPOUTS; PATIENT EDUCATION AS TOPIC; PRIMARY HEALTH CARE;

EID: 84882709841     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/dme.12230     Document Type: Article

References (34)

1. Williams R, Van Gaal L, Lucioni C; CODE-2 Advisory Board. Assessing the impact of complications on the costs of Type II diabetes. Diabetologia 2002; 45: S13-S17.
2. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-853.
3. Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with Type 2 diabetes. N Engl J Med 2003; 348: 383-393.
4. The ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008; 358: 2560-2572.
5. Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven PD, et al.;VADT Investigators. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 2009; 360: 129-139.
6. Gray A, Clarke P, Farmer A, Holman R; UK Prospective Diabetes Study (UKPDS) Group. Implementing intensive control of blood glucose concentration and blood pressure in type 2 diabetes in England: cost analysis (UKPDS 63). Br Med J 2002; 325: 860.
7. Gaede P, Valentine WJ, Palmer AJ, Tucker DM, Lammert M, Parving HH et al. Cost-effectiveness of intensified versus conventional multifactorial intervention in type 2 diabetes: results and projections from the Steno-2 study. Diabetes Care 2008; 31: 1510-1515.
8. Gagliardino JJ, de la Hera M, Siri F; Grupo de Investigacion de la Red Qualidiab. Evaluación de la calidad de la asistencia al paciente diabético en America Latina (Evaluation of the quality of care for diabetic patients in Latin America). Rev Panam Salud Publica/Pan Am J Public Health 2001; 10: 309-317.
9. Saaddine JB, Engelgau MM, Beckles GL, Gregg EW, Thompson TJ, Narayan KM. A diabetes report card for the United States: quality of care in the 1990s. Ann Intern Med 2002; 136: 565-574.
10. McGlynn EA, Asch SM, Adams J, Keesey J, Hicks J, DeCristofaro A et al. The quality of health care delivered to adults in the United States. N Engl J Med 2003; 348: 2635-2645.
11. Karter AJ, Stevens MR, Herman WH, Ettner S, Marrero DG, Safford MM, et al.;Translating Research Into Action for Diabetes Study Group. Out-of-pocket costs and diabetes preventive services: the Translating Research Into Action for Diabetes (TRIAD) study. Diabetes Care 2003; 26: 2294-2299.
12. Renders CM, Valk GD, de Sonnaville JJ, Twisk J, Kriegsman DM, Heine RJ et al. Quality of care for patients with Type 2 diabetes mellitus-a long-term comparison of two quality improvement programmes in the Netherlands. Diabet Med 2003; 20: 846-852.
13. Larme AC, Pugh JA. Attitudes of primary care providers toward diabetes: barriers to guideline implementation. Diabetes Care 1998; 21: 1391-1396.
14. Anderson RM, Fitzgerald JT, Funnell MM, Gruppen LD. The third version of the Diabetes Attitude Scale. Diabetes Care 1998; 21: 1403-1407.
15. Loveman E, Frampton GK, Clegg AJ. The clinical effectiveness of diabetes education models for Type 2 diabetes: a systematic review. Health Technol Assess 2008; 12: 1-116, iii.
16. Weingarten SR, Henning JM, Badamgarav E, Knight K, Hasselblad V, Gano A Jr et al. Interventions used in disease management programmes for patients with chronic illness-which ones work? Meta-analysis of published reports Br Med J 2002; 325: 925.
17. Gagliardino JJ, Olivera E, Etchegoyen GS, Guidi ML, Caporale JE, Martella A et al. PROPAT: a study to improve the quality and reduce the cost of diabetes care. Diabetes Res Clin Pract 2006; 72: 284-291.
18. Sidorov J, Shull R, Tomcavage J, Girolami S, Lawton N, Harris R. Does diabetes disease management save money and improve outcomes? A report of simultaneous short-term savings and quality improvement associated with a health maintenance organization-sponsored disease management program among patients fulfilling health employer data and information set criteria. Diabetes Care 2002; 25: 684-689.
19. Duke SAS, Colagiuri S, Colagiuri R. Individual patient education for people with type 2 diabetes mellitus. Cochrane Database Syst Rev 2009; 1: CD005268.
20. Gagliardino JJ, Lapertosa S, Villagra M, Caporale JE, Oliver P, Gonzalez C, et al.;on behalf of the PRODIACOR participating members. PRODIACOR: a patient-centered treatment program for type 2 diabetes and associated cardiovascular risk factors in the city of Corrientes, Argentina. Study design and baseline data. . Contemp Clin Trials 2007; 28: 548-556.
21. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2004; 27: S5-S10.
22. Gagliardino JJ, Etchegoyen G; PEDNID-LA Research Group. A model education program for people with type 2 diabetes: a cooperative Latin American implementation study (PEDNID-LA). Diabetes Care 2001; 24: 1001-1007.
23. Vinicor F, Cohen SJ, Mazzuca SA, Moorman N, Wheeler M, Kuebler T et al. DIABEDS: a randomized trial of the effects of physician and/or patient education on diabetes patient outcomes. J Chronic Dis 1987; 40: 345-356.
24. WHO. Mastering Depression in Primary Care. Info package. Frederisborg: World Health Organization, Regional Office for Europe, Psychiatric Research Unit, 1998.
25. Hollis S, Campbell F. What is meant by intention-to-treat analysis? Survey of published randomised controlled trials. Br Med J 1999; 319: 670-677.
26. Ruiz-Canela M, Martinez-Gonzalez MA, de Irala-Estevez J. Intention-to-treat analysis is related to methodological quality. Br Med J 2000; 320: 1007-1008.
27. Löwe B, Spitzer RL, Gräfe K, Kroenke K, Quenter A, Zipfel S et al. Comparative validity of three screening questionnaires for DSM-IV depressive disorders and physicians' diagnoses. J Affect Disord 2004; 78: 131-140.
28. Ellis SE, Speroff T, Dittus RS, Brown A, Pichert JW, Elasy TA. Diabetes patient counseling: a meta-analysis and meta-regression. Patient Educ Couns 2005; 52: 97-105.
29. Wagner EH, Grothaus LC, Sandhu N, Galvin MS, McGregor M, Artz K et al. Chronic care clinics for diabetes in primary care: a system-wide randomized trial. Diabetes Care 2001; 24: 695-700.
30. Davies MJ, Heller S, Skinner TC, Campbell MJ, Carey ME, Cradock S et al.; Diabetes Education and Self Management for Ongoing and Newly Diagnosed Collaborative. Effectiveness of the diabetes education and self management for ongoing and newly diagnosed (DESMOND) program for people with newly diagnosed type 2 diabetes: cluster randomised controlled trial. Br Med J 2008; 336: 491-495.
31. Brownson CA, Hoerger TJ, Fisher EB, Kilpatrick KE. Cost-effectiveness of diabetes self-management programs in community primary care settings. Diabetes Educ 2009; 35: 761-769.
32. Trento M, Gamba S, Gentile L, Grassi G, Miselli V, Morone G et al.; ROMEO Investigators. Rethink Organization to iMprove Education and Outcomes (ROMEO). A multicenter randomized trial of lifestyle intervention by group care to manage type 2 diabetes. Diabetes Care 2010; 33: 745-747.
33. Consumer Price Index from the Argentinean Statistics Office (INDEC). Available at http://www.indec.gov.ar/nuevaweb/cuadros/10/sh_ipc_2008.xls Last accessed 2 March 2012.
34. The Cochrane Collaboration. The Cochrane Handbook for Systematic Reviews of Interventions. Available at http://www.cochrane-handbook.org Last accessed 24 June 2012.